Jessica is a leading researcher in the field of precision medicine, focused on developing feasible frameworks to personalize clinical care for disease prevention and improved treatment across the spectrum of disease. Her pioneering work in integrative metabolomics has advanced the study of chronic diseases, in particular asthma, by integrating multiple omics datasets, including metabolomics, genomics, epigenomics, and proteomics for tangible clinical applications. A significant part of her research involves leveraging large-scale biobank data, such as the Mass General Brigham (MGB-Biobank), to investigate aging and chronic diseases in the context of multiomic data.
Her contributions to the field are reflected in her leadership roles, including serving as the president of the Metabolomics Society, chair the NIH’s Consortium of Metabolomics Studies (COMETS), where she has played a crucial role in shaping in how metabolomics is applied to epidemiological studies. Her dedication to precision medicine is evident in her efforts to identify robust biomarkers for biological aging and disease risk, ultimately contributing to more personalized and effective healthcare strategies. Through her mentorship, she has also fostered the development of future leaders in the field, many of whom have gone on to establish successful academic research careers.
